Literature DB >> 9391251

Gastric cancer below the age of 55: implications for screening patients with uncomplicated dyspepsia.

J Christie1, N A Shepherd, B W Codling, R M Valori.   

Abstract

AIMS: To test the hypothesis that gastric cancer presenting with uncomplicated dyspepsia is rare below the age of 55. PATIENTS AND METHODS: The area studied was the postcode defined catchment area of a district general hospital (Gloucestershire Royal) serving a population of 280,500. An open access endoscopy service has been available in this district for more than 17 years. All cases of gastric cancer during a seven year period (1986-92) were drawn from the local pathology database. The database of the neighbouring hospital and the South West Cancer Registry were searched for missed cases from the postcoded area. Hospital and general practitioner records were retrospectively reviewed with respect to duration of symptoms, and previous consultation and investigation for dyspepsia; and alarming symptoms and signs suggestive of underlying malignancy (unexplained recent weight loss, dysphagia, haematemesis or melaena, anaemia, previous gastric surgery, palpable mass, and perforation).
RESULTS: Twenty five of 319 cases of gastric cancer detected during the seven year period were aged less than 55. Twenty four of these 25 patients presented with one or more suspicious symptoms or signs. Only one patient (4%) aged less than 55 presented with uncomplicated dyspepsia. In two patients there was a delay in diagnosis of more than six months after first presenting to the general practitioner. Both these patients had significant symptoms at presentation.
CONCLUSION: Gastric cancer is rare below the of 55 (7.8% of all cases) and, even in the presence of established open access endoscopy, presents with suspicious symptoms or signs in 96% of cases. The age limit for screening uncomplicated dyspepsia can be raised safely to 55.

Entities:  

Mesh:

Year:  1997        PMID: 9391251      PMCID: PMC1891526          DOI: 10.1136/gut.41.4.513

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  13 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

Review 2.  Dyspepsia in general practice.

Authors:  C Brown; W D Rees
Journal:  BMJ       Date:  1990-03-31

3.  Open-access upper alimentary endoscopy.

Authors:  M W Gear; S P Wilkinson
Journal:  Br J Hosp Med       Date:  1989-05

4.  Early detection of gastric cancer.

Authors:  M T Hallissey; W H Allum; A J Jewkes; D J Ellis; J W Fielding
Journal:  BMJ       Date:  1990-09-15

5.  Gastric cancer: a curable disease in Britain.

Authors:  H M Sue-Ling; D Johnston; I G Martin; M F Dixon; M R Lansdown; M J McMahon; A T Axon
Journal:  BMJ       Date:  1993-09-04

6.  Gastric cancer: a 25-year review.

Authors:  W H Allum; D J Powell; C C McConkey; J W Fielding
Journal:  Br J Surg       Date:  1989-06       Impact factor: 6.939

7.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors:  A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

8.  Prevalence of symptoms of dyspepsia in the community.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1989-01-07

9.  Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia.

Authors:  P Bytzer; J M Hansen; O B Schaffalitzky de Muckadell
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

Review 10.  Screening for gastric cancer.

Authors:  S Hisamichi
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

View more
  23 in total

1.  Limited impact on endoscopy demand from a primary care based 'test and treat' dyspepsia management strategy: the results of a randomised controlled trial.

Authors:  Ian S Shaw; Roland M Valori; André Charlett; Cliodna A M McNulty
Journal:  Br J Gen Pract       Date:  2006-05       Impact factor: 5.386

2.  Does endoscopy diagnose early gastrointestinal cancer in patients with uncomplicated dyspepsia?

Authors:  N Sundar; V Muraleedharan; J Pandit; J T Green; R Crimmins; G L Swift
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 3.  How should Helicobacter pylori positive dyspeptic patients be managed?

Authors:  N J Talley
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  Predictive value of alarm features in a rapid access upper gastrointestinal cancer service.

Authors:  N Kapoor; A Bassi; R Sturgess; K Bodger
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

5.  Comparative outcome of oesophagogastric cancer in younger patients.

Authors:  Samir P Mehta; Diana Bailey; Nick Davies
Journal:  Ann R Coll Surg Engl       Date:  2010-06-01       Impact factor: 1.891

6.  Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study.

Authors:  M B Wallace; V L Durkalski; J Vaughan; Y Y Palesch; E D Libby; P S Jowell; N J Nickl; S M Schutz; J W Leung; P B Cotton
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

7.  Reducing community dyspepsia drug costs: a controlled trial.

Authors:  R M Valori; C M Brown; P Strangeways; M Bradburn
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

8.  Upper gastrointestinal cancer in its early stages is predominantly asymptomatic.

Authors:  James W Berrill; Jeff K Turner; Jo J Hurley; Gillian Swift; Sunil Dolwani; John T Green
Journal:  Frontline Gastroenterol       Date:  2011-09-10

9.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

10.  Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.

Authors:  J Hammer; G D Eslick; S C Howell; E Altiparmak; N J Talley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.